Detalhe da pesquisa
1.
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy.
Br J Cancer
; 129(6): 1022-1031, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507543
2.
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.
Br J Cancer
; 127(3): 488-499, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501389
3.
Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).
Thorax
; 76(1): 86-88, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097604
4.
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells.
Invest New Drugs
; 39(2): 587-594, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33052557
5.
Bidirectional KCNQ1:ß-catenin interaction drives colorectal cancer cell differentiation.
Proc Natl Acad Sci U S A
; 114(16): 4159-4164, 2017 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28373572
6.
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
BMC Cancer
; 18(1): 965, 2018 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30305055
7.
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
Breast Cancer Res
; 19(1): 87, 2017 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28750640
8.
Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.
Cell Immunol
; 319: 35-42, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28735814
9.
ADAM10: a new player in breast cancer progression?
Br J Cancer
; 113(6): 945-51, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26284334
10.
Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression.
BMC Cancer
; 15: 329, 2015 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25924769
11.
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.
Mol Cancer
; 13: 241, 2014 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344116
12.
Familial Variability of Disease Severity in Adult Patients With ADPKD.
Kidney Int Rep
; 9(3): 649-660, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38481516
13.
Donor genetic burden for cerebrovascular risk and kidney transplant outcome.
J Nephrol
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809363
14.
Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis.
Carcinogenesis
; 34(10): 2300-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740839
15.
BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.
Breast Cancer Res
; 15(4): R52, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23820017
16.
A gene expression profile indicative of early stage HER2 targeted therapy response.
Mol Cancer
; 12: 69, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23816254
17.
Gene expression analysis in prostate cancer: the importance of the endogenous control.
Prostate
; 73(4): 382-90, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22926970
18.
Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?
Prostate
; 73(7): 743-53, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23359479
19.
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
BMC Cancer
; 13: 175, 2013 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23547718
20.
Characterization and response of newly developed high-grade glioma cultures to the tyrosine kinase inhibitors, erlotinib, gefitinib and imatinib.
Exp Cell Res
; 318(5): 641-52, 2012 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22285130